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Purpose: Primary open angle glaucoma (POAG) is a leading cause of irreversible blindness in the elderly.
Previous epidemiological studies have identiﬁed family history, ethnic origin, age, high intraocular pres-
sure and diabetes mellitus as risk factors. However, it is difﬁcult to assess the extent family history plays
in this disease process. The Utah Population Database (UPDB), created by the University of Utah, has
recently become a resource for which greater than 9 million records are available for use. The UPDB is
divided into two major data sets from which family members can be identiﬁed, namely 1.6 million gene-
alogy records and 2 million Utah birth certiﬁcates. This study utilizes these resources to assess the famil-
ial risk of POAG within the Utah Population.
Methods: The University of Utah’s hospital and clinic records were searched for patients with primary
and chronic open angle glaucoma (ICD9 codes 365.04 and 365.11) between the years 1995 and 2005.
A case-control analysis was then performed with specialized UPDB software that was modiﬁed to con-
strain the control and pedigree populations to over 1 million University of Utah-UPDB linked records.
Controls were matched to cases by gender and birth year (±2.5 years) with only one control being used
per case. Population-attributable risk (PAR) to familial factors and relative risk (RR) were computed using
conditional logistic regression (CLR).
Results: From the original 1.5 million medical records, 6198 patients with glaucoma were identiﬁed. Of
these, 3391 met the inclusion criteria, which required patients to have at least one parent or one child
in the UPDB. The PAR in this population was found to be 0.20, indicating 20% of the risk for glaucoma
is attributable to genetic factors. CLR computations also showed a signiﬁcantly increased relative risk
(p < 0.05) in ﬁrst cousins (RR = 1.45 (95% conﬁdence interval (CI) 1.16–1.8)), second cousins (RR = 1.19
(95% CI 1.08–1.32)), siblings (RR = 3.76 (95% CI 2.66–5.31)), parents (RR = 6.25 (95% CI 3.94–9.9)) and
children (RR = 6.77 (95% CI 3.39–13.5)).
Conclusions: Based on these familial data, there is a signiﬁcantly higher prevalence of glaucoma in both
ﬁrst and second generation relatives of those affected as compared to relatives in the control group.
When compared with other epidemiologic studies, such as an analysis of ﬁrst-degree relatives of patients
from the Rotterdam study, which showed a PAR of 16%, our study actually demonstrates a greater familial
contribution to glaucoma. The UPDB is a valuable and unique resource providing a large population from
which to analyze the familial risk of glaucoma.
Published by Elsevier Ltd.1. Introduction
Primary open angle glaucoma (POAG) is the world’s second
most common cause of irreversible blindness in the elderly
(Quigley, 1996). Several large population-based studies have foundLtd.
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ang), kangzhang@ucsd.eduthe prevalence of POAG to range from 1.1% to 3.0% in predomi-
nately white populations (Coffey et al., 1993; Dielemans et al.,
1994; Klein et al., 1992; Mitchell, Smith, Attebo, & Healey, 1996;
Tielsch et al., 1991) and 4.2% to 8.8% in black populations (Leske,
Connell, Schachat, & Hyman, 1994; Mason et al., 1989; Tielsch
et al., 1991). Additionally, it is predicted that the anticipated
increase in the population over 40 years of age between 2010
and 2020 will cause a 30% rise in the prevalence of glaucoma
during this time period, from 60.5 million to 79.6 million people
(Quigley & Broman, 2006).
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sual function resulting from retinal ganglion cell death and pro-
gressive atrophy of the optic nerve. It is characterized by an
excavated appearance of the optic disc on exam (Quigley, 1993).
The disease is often associated with elevated intraocular pressure
(IOP) (Leske, 1983) and decreased retinal nerve ﬁber layer thick-
ness and optic disc rim area, both of which indicate loss of retinal
ganglion cells (Jonas, Budde, & Panda-Jonas, 1999; Quigley, 1999;
Tuulonen & Airaksinen, 1991).
While the cause of POAG is unclear, previous epidemiological
studies have identiﬁed family history, ethnic origin, age, and ele-
vated IOP as risk factors (Tielsch, Katz, Sommer, Quigley, & Javitt,
1994; Wolfs et al., 1998). Other reported risk factors include diabe-
tes mellitus, hypertension, and lifestyle factors such as smoking
and alcohol consumption (Daubs & Crick, 1981; Dielemans et al.,
1995; Katz & Sommer, 1988; Klein, Klein, & Jensen, 1994; Mitchell,
Smith, Chey, & Healey, 1997; Tielsch, Katz, Quigley, Javitt, &
Sommer, 1995; Wilson, Hertzmark, Walker, Childs-Shaw, &
Epstein, 1987). However, many of these reported associations are
still under debate (Klein, Klein, & Ritter, 1993; Leske, Wu, Hennis,
Honkanen, & Nemesure, 2008; Tielsch et al., 1995; Tielsch, Katz,
Sommer, Quigley, & Javitt, 1995).
Many clinical studies have documented the familial aggregation
of POAG. First-degree relatives of patients with POAG have a re-
ported 7–10-fold increased risk of developing the disease when
compared to the general population (Drance, Schulzer, Thomas, &
Douglas, 1981; Wolfs et al., 1998). Additionally, Teikari et al. ob-
served a high concordance of disease between monozygotic twins
(Teikari, 1987). Other studies have performed genome-wide scans
that have revealed 20 possible genetic loci (Supplementary Table 1).
One promising locus is GLC1I. Allingham et al. showed that it con-
tributed an estimated 17% attributable risk in 15 out of 86multiplex
familieswith POAG stratiﬁed for analysis on the basis of age of onset
of disease (Allingham et al., 2005). Woodroffe et al. corroborated
that one or more genes on this locus may account for over half of
the POAG families in their cohort (Woodroffe et al., 2006). The num-
ber of loci associated with POAG, therefore, provides strong evi-
dence for the polygenic nature of this disease. Recent work has
identiﬁed three additional genes (MYOC, OPTN, WDR36) associated
with POAG (Monemi et al., 2005; Rezaie et al., 2002; Stone et al.,
1997). Although these discoveries are promising, it is estimated that
these three genes likely contribute to the pathogenesis of POAG in
<5% of cases in the general population (Alward et al., 2002, 2003;
Fingert et al., 1999; Hewitt, Dimasi, Mackey, & Craig, 2006; Leung
et al., 2003). Thus, it seems that the genetic explanation for a signif-
icant percentage of POAG patients is yet to be discovered.
While it seems clear that family history contributes to glaucoma
susceptibility, the degree to which genetics plays a role is not
apparent. Large pedigrees of glaucoma patients may aid current
and future genetic association studies by demonstrating the herita-
bility of glaucoma-contributing genes, or even uncovering related
genetic polymorphisms. The Utah Population Database (UPDB),
created by the University of Utah, is a resource of over 9 million re-
cords, which can be utilized to identify large pedigrees of families
affected by different diseases. Other studies have used the data-
base to investigate the familial aggregation of ocular disease, such
as AMD (Luo et al., 2008). The appeal to perform genetic research
in Utah has been described by us previously and stems from Utah’s
unique population of larger families and minimization of environ-
mental factors (Luo et al., 2008). The purpose of this study was to
utilize UPDB to assess the familial risk of POAG.
2. Methods
The study is a population-based retrospective case-control
study utilizing data from the UPDB. The UPDB contains data fromthe Family History Library maintained by the Church of Jesus Christ
of Latter-Day Saints (LDS), Utah State Department of Health, and
other statewide data sets (http://www.hci.utah.edu/groups/ppr/
data.html). The UPDB is linked to the University of Utah Health Sci-
ences Center (UUHSC) and allows for the identiﬁcation of large
pedigrees. From this, calculations of population-based risks of dis-
ease, such as POAG, can be determined. Previous work in our lab
has described this data set and how it can be used in identifying
affected families (Luo et al., 2008).
This study has been approved by the University of Utah IRB and
the Utah Research for Genetic and Epidemiological Research (RGE).
The RGE is the administrative body for the UPDB (Wylie & Mineau,
2003).
2.1. Open angle glaucoma cases
The University of Utah’s 1.5 million hospital and clinic records
were searched for patients with primary and chronic open angle
glaucoma (ICD9 codes 365.04 and 365.11) between the years
1995 and 2005. A total of 6198 patients were identiﬁed. Inclusion
criteria required patients to have at least one parent or one child in
the UPDB in order to be used for further familial statistical assess-
ments. Of the cases identiﬁed, 3391 had adequate pedigree infor-
mation in the UPDB and were included in the population-
attributable risk (PAR) and relative risk (RR) analyses.
2.2. Population controls
After identiﬁcation of POAG cases, controls were chosen from
the UUHSC-UPDB cohort. Only controls with family information re-
corded in the UPDB were used for the study. Controls were
matched to cases by gender, birth year (±2.5 years), presence in
the linked UUHSC-UPDB set, and absence of POAG diagnosis. One
control was selected for each case and each control was unique.
The controls were chosen from UUHSC database where a normal
eye examination was recorded.
A case-control analysis was then performed with specialized
UPDB software that was modiﬁed to constrain the control and ped-
igree populations to over 1 million UUHSC-UPDB linked records.
PAR and RR were computed using conditional logistic regression
(CLR).
2.3. Statistical analyses
2.3.1. Familial standardized incidence ratio (FSIR)
The FSIR (Kerber, 1995) permits quantiﬁcation of an individual’s
familial risk of disease, taking into account the number of biologi-
cal relatives, degree of relatedness to the proband, and person-time
at risk among family members. FSIR is calculated by tabulating the
observed and expected numbers of cases of disease among all of an
individual’s relatives, weighting the contribution of each relative
by the probability that the relative shares an allele with the subject
by common descent. Boucher and Kerber describe an empirical
Bayes adjustment for measurement error (Boucher & Kerber,
2001).
2.3.2. Population-attributable risk
PAR was calculated using a conditional logistic regression meth-
od described by Bruzzi (Bruzzi, Green, Byar, Brinton, & Schairer,
1985). First, a conditional logistic regression model is used to pre-
dict relative risk as a function of FSIR. From this model, individual
probabilities of causation for each case are computed as (RR-1)/RR,
where RR is the relative risk estimated from the model for the ob-
served level of FSIR. The mean probability of causation across all
the cases is the population-attributable risk.
Table 2
Population-attributable risk (PAR) for POAG.
Attributable Risk (CLR)
PAR CI
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RRs for parents, siblings, and ﬁrst and second cousins of the
3391 cases were calculated using unconditional logistic regression,
following the method described by Bai et al. (Bai, Sherman, Khoury,
& Flanders, 2000).Raw 0.14 0.10–0.17
Adjusted 0.20 0.13–0.26
Table 3
Eleven families identiﬁed from the Utah Population Database.2.3.4. Pedigree p-values
Theprobabilityof a familyhavingsomeobservednumberof cases
(x), under the null hypothesis of no familial disease aggregation, is
the Poisson probability of XP x given an expected number, l.Cluster Descendants Observed Expected FSIR p-Value
Cluster 1a 6110 13 4.4651 2.9115 0.0008
Cluster 1b 3334 8 2.0278 3.9452 0.0012
Cluster 1a 1480 6 0.8622 6.9592 0.0003
Cluster 1c 1814 5 1.2846 3.8922 0.0102
Cluster 1d 6968 12 4.8393 2.4797 0.0043
Cluster 2a 547 5 0.3481 14.3651 0
Cluster 2b 1633 5 1.2289 4.0687 0.0085
Cluster 2c 1129 5 0.7733 6.4661 0.0012
Cluster 2d 1198 5 0.9173 5.4507 0.0025
Cluster 3 1581 5 1.1006 4.5429 0.0054
Cluster 4 2192 5 1.3715 3.6457 0.0132
Cluster 5a 1107 5 0.5206 9.6034 0.0002
Cluster 5b 1328 5 0.7309 6.8409 0.001
Cluster 6 1229 5 1.0571 4.7301 0.0046
Cluster 7 3126 9 2.5837 3.4834 0.0014
Cluster 8 2492 6 1.9213 3.1228 0.0139
Cluster 9 2158 5 1.1768 4.2487 0.0072
Cluster 10 2342 7 1.906 3.6726 0.0035
Cluster 11a 2627 6 1.4913 4.0234 0.0043
Cluster 11b 1980 5 1.0528 4.7494 0.0045
Cluster 11c 2091 6 1.2151 4.9377 0.0016
Cluster 11d 2099 5 0.9735 5.1363 0.00333. Results
From the original 1.5 million medical records, 6198 patients
with glaucoma were identiﬁed. Of these, 3391 patients met inclu-
sion criteria and were used in the study. The POAG cases and con-
trols were analyzed to determine various risks of disease
development by relation to the proband in order to demonstrate
the familial risk of POAG. Cases and controls are displayed in
Table 1.
The PAR was found to be 0.14 and the adjusted PAR was found
to be 0.20, indicating 20% of the risk for glaucoma is attributable to
a genetic factor (Table 2). CLR computations also showed increased
RR in ﬁrst cousins, second cousins, siblings, parents, and children of
the proband (Table 1).
Eleven large pedigrees having at least 5 affected family mem-
bers are shown in Table 3. These families have a signiﬁcantly in-
creased FSIR (p-value < 0.05), indicating a greater prevalence of
glaucoma when compared to the population controls, and, further
underscoring the familial aggregation of POAG in the Utah Popula-
tion. The kinship analysis software provided each family with a
founder Person ID, number of descendents, observed number of af-
fected, expected number of affected, FSIR, and standard error. Data
such as birth year, death year, and gender on pedigree founders
and all affected cases was given for each familial cluster. Findings
were reviewed and careful manual analysis of each affected case
identiﬁed in the clusters was performed. Large pedigrees were
drawn out using Peddraw software, two of which are shown in
Figs. 1a and 1b. Twenty-two families were identiﬁed as having ﬁve
or more living affected family members. In each family, the p-value
under the null hypothesis of no familial disease aggregation is
<0.05 and the FSIR is >.0. The family members within the pedigrees
were compared and reduced to 11 extended large families due to
common ancestry. In some instances multiple founders were iden-
tiﬁed for the same group of cases, which is annotated in Table 3
with the cluster number followed by a letter corresponding to
the different founder. Of the 3391 individuals with POAG from
the study cohort, 138 individuals fall into the 11 extended pedi-
grees. Descendents and FSIR for each family ranged from 547 to
6968 and 2.91 to 14.37, respectively (Table 3). Likewise, the med-
ian number of descendents and median FSIR in each pedigree was
2298 and 5.15 respectively, derived from the data in Table 3. The
large number of descendents and elevated FSIR indicate a strong
familial aggregation of POAG in Utah families.Table 1
Number of cases, controls and relative risk of different relationships to probands for POAG
Relationship Cases (n = 3391) Controls (n
Affected Unaffected Affected
Parent 141(3.28%) 4159(96.72%) 20(0.54%)
Sibling 154(7.35%) 1942(92.65%) 42(2.11%)
First cousin 195(2.14%) 8922(97.86%) 138(1.48%)
Second cousin 813(1.61%) 49709(98.39%) 728(1.36%)4. Discussion
Our study conﬁrms a genetic component to POAG, which is
likely to have a complex, multifactorial inheritance pattern. Based
on the familial data gathered from the UUHSC-UPDB cohort, there
is a signiﬁcantly higher prevalence of glaucoma in both ﬁrst and
second degree relatives than the relatives in the control group
(p-value < 0.05). While previous studies have shown that ﬁrst-de-
gree relatives of glaucoma patients have the highest risk of devel-
oping glaucoma, some of these studies do not consider second
degree relatives (Leighton, 1976; Sung et al., 2006). Data on rela-
tives extending beyond ﬁrst degree is less studied, and an in-
creased relative risk in both ﬁrst (RR = 1.45) and second
(RR = 1.19) cousins as shown by this study may indicate a stronger
genetic component to POAG than previously recognized, especially
when taking into account the small number of alleles shared by
second cousins (2%). Furthermore, a design looking at only ﬁrst-de-
gree relatives may underestimate the genetic nature of glaucoma,
especially if incomplete penetrance of glaucoma genes is present
(Green et al., 2007).
Our study found the PAR of POAG to be 20%. Other epidemiol-
ogic analysis, such as the study by Wolfs, which analyzed ﬁrst-
degree relatives of patients from the Rotterdam study, showed a.
= 3391) Relative risk (95%CI) p-Value
Unaffected
3677(99.46%) 6.25(3.94–9.9) 5.7  1015
1949(97.89%) 3.76(2.66–5.31) 6.12  1014
9215(98.52%) 1.45(1.16–1.8) 0.00104
52895(98.64%) 1.19(1.08–1.32) 0.000601
Fig. 1a. POAG Family 1 Pedigree.
Fig. 1b. POAG Family 2 Pedigree.
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greater familial contribution to glaucoma. This may be due to the
large number of patients used in our population (n = 3391) com-
pared to the Rotterdam study (n = 48). As previously described
by our lab, the UPDB is a biologically representative sample of a
broad spectrum of the United States Caucasian population and
has a similar genetic makeup to other Northern European-derived
populations (Luo et al., 2008). Additionally, Goldgar et al. reported
that the relative risks of cancer and other diseases calculated for
the Utah Population are similar to published estimates of other
populations (Goldgar, Easton, Cannon-Albright, & Skolnick, 1994).
Furthermore, consanguinity rates in Utah are similar to the US pop-
ulation as described by Jorde (1989) and McLellan, Jorde, and Skol-
nick (1984). Thus, we feel that the relative risk calculations from
the UPDB can be applied to other communities.
The extensive POAG pedigrees identiﬁed in this study may help
shed further light on the genetics and pathogenesis of POAG. We
have contacted several members of these large pedigrees and col-
lected blood samples and additional data, which may becomemore
valuable as new genetic discoveries are made. Additionally, while
the possibility of underlying genetic heterogeneity for disease
may dampen the excitement of linkage studies, this limitation
may be attenuated by extended pedigrees with large numbers of
affected patients. A few large, independently informative pedi-
grees, such as those identiﬁed in this study, may help ﬁnd new
linked regions for POAG and provide more clarity and narrower re-
gions in currently identiﬁed loci. Furthermore, the large number of
descendents and elevated FSIR within these large pedigrees indi-
cate a strong familial aggregation of POAG in Utah families, thus
showing the utility of the linked UPDB-UUHSC records and kinship
analysis software in providing the basis to identify and recruit ex-
tended families with clustering of POAG.
Our study is not without limitations. The number of cases in the
UUHSC-UPDB cohort may be somewhat conservative from under-
diagnosis due to selection bias, as an assumption of unaffected sta-
tus was made when there was no POAG diagnosis recorded in the
UUHSC system. The UUHSC system is only one of many healthcareproviders in the state of Utah and some POAG patients are certainly
receiving care from other providers. However, the UPDB is cur-
rently working with these providers to incorporate their medical
records into our database, which would help further delineate
POAG status in our study population. Our study is ongoing and
we will re-assess our population periodically in the future to in-
clude newly collected patient data into our database.
Another limitation of our study is the lack of environmental
data such as diet and smoking history. This was not included in
the UPDB and was not collected at the time of this study. However,
this data can be collected in the future and may prove useful in
enhancing further study efforts.
The PAR and RR ﬁndings in this study demonstrate the familial
aggregation of POAG in the Utah Population. Due to the genetic
make up of the cohort and its similarity to other populations in
the U.S. and elsewhere, these ﬁndings can reasonably be extended
to other communities. Our risk assessment and pedigree ﬁndings
contribute to the understanding of the role of genetics in POAG,
and this may lead to a better understanding of the pathogenesis
of POAG in the future. The UPDB is a valuable and unique resource
providing a large population from which to analyze familial risk
and large pedigrees with several affected members of glaucoma,
and may be used in future research for genetic analysis of other
common ocular diseases such as diabetic retinopathy.Acknowledgments
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